IP Library Patent Application 16646594
Patent Application
App. No. 16/646,594

METHODS OF TREATING DISEASES ASSOCIATED WITH VASCULAR SMOOTH MUSCLE CELL PROLIFERATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/646,594
Abstract

A method of treating a disease associated with vascular smooth muscle cell proliferation in a subject in need thereof is provided with the proviso that the disease is not cancer. The method comprises administering to the subject a therapeutically effective amount of a CXCR4-antagonistic peptide comprising SEQ ID NO: 1, thereby treating the disease.

Claims (9)

1 . A method of treating a disease associated with vascular smooth muscle cell proliferation in a subject in need thereof, with the proviso that the disease is not cancer, the method comprising administering to the subject a therapeutically effective amount of a CXCR4-antagonistic peptide comprising SEQ ID NO: 1, thereby treating the disease.

2 . (canceled)

3 . A device for cardiac delivery comprising a CXCR4-antagonistic peptide comprising SEQ ID NO. 1.

4 . The method of claim 1 , wherein said disease is a cardiac disease.

5 . The method of claim 4 , wherein said cardiac disease is selected from the group consisting of cardiac hypertrophy, transplant arteriosclerosis, atherosclerosis, angioplasty restenosis, ventricular stenosis or cardiac vein bypass stenosis.

6 . The method of claim 1 , wherein said disease is selected from the group consisting of essential hypertension, thrombosis, stenosis, ventricular stenosis, diabetic macroangiopathy, myocardial infarction, stroke, vascular dementia, intimal hyperplasia, restenosis, angioplasty restenosis, cardiac vein bypass stenosis, transplant arteriosclerosis and atherosclerosis.

7 . The method of claim 1 , wherein said administering comprises local administering.

8 . (canceled)

9 . The device of claim 3 , being a stent or a catheter.

Assignments (3)
SECURITY INTEREST Recorded Oct 27, 2020
From: BIOLINE RX LTD.
To: KREOS CAPITAL V (EXPERT FUND) L.P.
Reel/Frame 054172/0318 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2020
From: PELED, AMNON
To: BIOLINERX LTD.; BIOKINE THERAPEUTICS LTD.
Reel/Frame 053772/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2020
From: PELED, AMNON
To: BIOLINERX LTD.; BIOKINE THERAPEUTICS LTD.
Reel/Frame 053429/0486 →